Fjarde AP Fonden Fourth Swedish National Pension Fund Reduces Holdings in Ralliant Corporation $RAL

Fjarde AP Fonden Fourth Swedish National Pension Fund lowered its position in shares of Ralliant Corporation (NYSE:RAL) by 93.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,305 shares of the company’s stock after selling 17,468 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Ralliant were worth $57,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Dodge & Cox acquired a new position in Ralliant during the second quarter worth approximately $523,571,000. Viking Global Investors LP purchased a new position in shares of Ralliant during the second quarter worth approximately $257,200,000. State Street Corp acquired a new position in shares of Ralliant in the 2nd quarter valued at $213,096,000. Flossbach Von Storch SE purchased a new stake in Ralliant in the 2nd quarter valued at $198,077,000. Finally, Norges Bank purchased a new stake in Ralliant in the 2nd quarter valued at $108,453,000.

Ralliant Stock Down 0.7%

Shares of RAL opened at $53.51 on Tuesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.49 and a quick ratio of 1.03. Ralliant Corporation has a 52-week low of $40.70 and a 52-week high of $55.08. The company has a 50-day moving average of $50.27. The stock has a market cap of $6.04 billion and a P/E ratio of 42.13.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.02. The company had revenue of $529.10 million for the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Monday, December 8th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $0.20 annualized dividend and a yield of 0.4%. Ralliant’s payout ratio is currently 15.75%.

Analysts Set New Price Targets

A number of research firms have commented on RAL. Weiss Ratings restated a “hold (c)” rating on shares of Ralliant in a research note on Monday, December 29th. Citigroup raised Ralliant from a “neutral” rating to a “buy” rating and raised their price target for the stock from $53.00 to $61.00 in a report on Monday, December 8th. Truist Financial assumed coverage on Ralliant in a research note on Friday, December 12th. They set a “buy” rating and a $62.00 price objective for the company. Barclays increased their price objective on Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. Finally, Oppenheimer boosted their target price on Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $58.00.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.